TABLE 1.
Characteristics of study serum samples from areas of endemicity in Korea, Myanmar, and China
| Characteristic | Value |
||||||
|---|---|---|---|---|---|---|---|
| Acutely infected subjects |
Recovery subjects |
Healthy subjects (Korea) | |||||
| Korea (group 1) | Korea (group 2) | Myanmar | China | 5 yra | 12 yrb | ||
| Total (n) | 56 | 40 | 40 | 20 | 30 | 30 | 40 |
| Sex ratio (male:female) | 13:1 | 12.3:1 | 4:1 | 1.5:1 | 1.3:1 | 2:1 | 1:1 |
| Age (yr) | |||||||
| Mean (SD) | 33.89 (13.20) | 27.73 (9.80) | 22.88 (7.49) | 35.65 (16.14) | 52.47 (22.52) | 49.27 (16.47) | 10.00 (2.44) |
| Range | 13–72 | 18–59 | 10–42 | 17–58 | 7–85 | 19–78 | 6–13 |
| Parasitemia (%) | |||||||
| Mean (SD) | 0.15 (0.16) | 0.14 (0.15) | 0.10 (0.13) | 0.13 (0.15) | |||
| Range | 0.02–0.75 | 0.01–0.74 | 0.01–0.80 | 0.01–0.51 | |||
a
5 yr, infected with vivax malaria in 2007 with no record of malaria infection in the past 5 years in China.
b
12 yr, infected with vivax malaria in 2000 with no record of malaria infection in the past 12 years in China.